Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. MartensDOCMF 55 Days Sales Outstanding is 31.31 as of Mar. 2026, which is 20% above its 10-year median of 26.15. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,030 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 75.63% on this metric.
Dr. Martens's average Accounts Receivable for the
six
months ended in Mar. 2026 was $101 Mil. Dr. Martens's Revenue for the
six
months ended in Mar. 2026 was $591 Mil.
Hence, Dr. Martens's Days Sales Outstanding for the
six
months ended in Mar. 2026 was 31.31.
The historical rank and industry rank for Dr. Martens's Days Sales Outstanding or its related term are showing as below:
DOCMF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.1 Med: 26.15 Max: 31.88
Current: 31.88
During the past 9 years, Dr. Martens's highest Days Sales Outstanding was 31.88. The lowest was 24.10. And the median was 26.15.
DOCMF's Days Sales Outstanding is ranked better than 75.63% of 1030
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 52.28
vs DOCMF: 31.88
Dr. Martens's Days Sales Outstanding
increased
from Mar. 2025 (27.91) to Mar. 2026 (31.31).
Dr. Martens (OTCPK:DOCMF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Dr. Martens Days Sales Outstanding Related Terms
Dr. Martens Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCMF vs NKE, DECK, ONON: Days Sales Outstanding Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Days Sales Outstanding vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (DOCMF) has a Days Sales Outstanding of 31.31 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Dr. Martens and its competitors. This is 20% above median its historical median of 26.15. Over the past decade, Dr. Martens' Days Sales Outstanding has ranged from 24.10 to 31.88. According to the industry distribution chart, Dr. Martens ranks #251 out of 1030 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 24.4%.
Is Dr. Martens' Days Sales Outstanding too high?
Dr. Martens' current Days Sales Outstanding of 31.31 is 20% above median its 10-year median of 26.15. Over the past 10 years, this metric has ranged from a low of 24.10 to a high of 31.88. The Manufacturing - Apparel & Accessories industry median Days Sales Outstanding is 52.28. Dr. Martens' value of 31.31 is 40.1% below this industry median. Based on the distribution chart, Dr. Martens ranks #251 out of 1030 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Days Sales Outstanding compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #251 out of 1030 companies for Days Sales Outstanding. This places Dr. Martens in the top 24% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 52.28. Dr. Martens' value of 31.31 is 40.1% below this benchmark. Historically, Dr. Martens' own Days Sales Outstanding has ranged from 24.10 to 31.88 over the past decade. While the company's 10-year median is 26.15 vs. the industry median of 52.28, Dr. Martens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Manufacturing - Apparel & Accessories company?
The median Days Sales Outstanding among Manufacturing - Apparel & Accessories companies is 52.28, based on 1,030 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Days Sales Outstanding of 31.31 is 40.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Days Sales Outstanding is 52.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Days Sales Outstanding is 31.31, which is 20% above median its own 10-year median of 26.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $1.03 — trading 6.2% above its estimated fair value. The current Days Sales Outstanding is 31.31, which is 20% above median its 10-year median of 26.15 and 40.1% below the Manufacturing - Apparel & Accessories industry median of 52.28. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Days Sales Outstanding is 31.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of $1.03 is trading 6.2% above its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DOCMF:
Days Sales Outstanding: 31.31 (20% above median its 10-year median of 26.15)
GF Value™: $0.97 vs. price of $1.03 (6.2% above fair value)
Industry Position: 40.1% below the Manufacturing - Apparel & Accessories median (#251 of 1030)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
